Reuters logo
Valeant sees 'unrivaled' growth in possible Allergan merger
April 21, 2014 / 9:40 PM / 3 years ago

Valeant sees 'unrivaled' growth in possible Allergan merger

(Reuters) - A merger between Valeant Pharmaceuticals International Inc (VRX.TO) and Allergan Inc (AGN.N) would create an “unrivaled platform for growth and value creation” in the healthcare sector, a spokesperson for Valeant said on Monday.

Valeant will finalize and announce terms of its proposal shortly, the spokesperson said.

Reporting by Rod Nickel. Editing by Andre Grenon

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below